Streetbeat News

Products Services

AMZN

DASH

Amazon Canada has partnered with DoorDash to offer a free one-year DashPass membership for Prime members. This collaboration aims to provide additional benefits to Amazon Prime members and expand DoorDash's customer base.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:13 pm

ZVSA

ZyVersa Therapeutics announced that the European Patent Office will grant a patent application covering the company's Phase 2a-ready cholesterol efflux mediator VAR 200 for use in diabetic nephropathy/diabetic kidney disease.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:12 pm

AAPL

COIN

DIS

GME

HOTH

Top 5 stocks to watch on June 6, 2023 include Apple, Disney, Coinbase, GameStop, and Hoth Therapeutics. Apple's WWDC presentation received mixed analyst reactions, Disney is undervalued according to Morgan Stanley, Coinbase faces an SEC lawsuit, GameStop prepares to report quarterly results, and Hoth Therapeutics' Alzheimer's treatment shows promising pre-clinical results.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:08 pm

SNOW

Snowflake has launched a new Government and Education Data Cloud, aiming to provide secure and scalable data solutions for public sector organizations.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:03 pm

LULU

XPOF

lululemon and Xponential Fitness have renewed their partnership, with Xponential Fitness increasing the number of workouts from Pure Barre, Rumble, AKT, and YogaSix on the lululemon Studio platform. This collaboration builds upon the initial launch in October and expands Xponential Fitness's digital presence.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:03 pm

JSDA

Jones Soda Co. announced the launch of two new flavors, MF Grape and Cola, for its Mary Jones cannabis-infused beverage brand. The products will be available at California dispensaries in June 2023, with more states to follow later in the year.

Portfolio Pulse from Vuk Zdinjak

June 06, 2023 | 1:00 pm

ERAS

Erasca Inc (NASDAQ:ERAS) is discontinuing certain pipeline programs due to lack of clinical activity and will focus on programs with encouraging activity signals. The company will deprioritize ERAS-9, ERAS-11, and ERAS-2/3, but continue pursuing other research approaches to target RAS mutations. Preliminary Phase 1b data for ERAS-007 in patients with metastatic BRAF V600E-mutated colorectal cancer showed a 50% response rate at the highest dose.

Portfolio Pulse from Vandana Singh

June 06, 2023 | 12:53 pm

AAPL

Apple Inc. unveiled its Vision Pro mixed reality headset at the Worldwide Developers Conference 2023. Tech YouTuber Marquee Brownlee praised the device's eye-tracking sensors and user interface but expressed concerns about its weight and potential discomfort during extended use. The headset is priced at $3,499 and set to launch in the U.S. in early 2024.

Portfolio Pulse from Ananya Gairola

June 06, 2023 | 12:45 pm

HOTH

MREO

ZURA

Hoth Therapeutics announces positive preclinical results for HT-ALZ Alzheimer's treatment, Zura Bio completes $80 million financing to advance ZB-106, and Needham reiterates buy on Mereo BioPharma with a $5 price target.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 12:37 pm

ABVC

ABCV Biopharma has announced a collaboration with Merdury Biopharma for the development and commercialization of new products. This partnership aims to leverage the expertise of both companies to bring innovative solutions to the market.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 12:34 pm